Your session is about to expire
← Back to Search
Diagnostic MRI + Gene Expression for Breast Cancer
Study Summary
This trial looks at using MRI and gene expression to diagnose patients with abnormal cells in the breast duct. It may help doctors predict a patient's response to treatment and help plan the best treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have harmful BRCA gene mutations.Women who could become pregnant must have a recent test to make sure they are not pregnant before joining the study.I am using or will use effective birth control or abstain from sex during the study.I have had an MRI and any other necessary tests as indicated.My last surgery removed all visible cancer with clear margins, and I have DCIS.I have a confirmed diagnosis of ductal carcinoma in situ without invasive disease, diagnosed within the last 4 months.I haven't taken hormone therapy for breast cancer prevention in the last 3 months.I haven't had chemotherapy for any cancer in the last 6 months.I have never had breast radiotherapy that would stop me from getting it now for DCIS.I can safely have an MRI with gadolinium contrast.I've had a mammogram of both breasts within 6 months and of the affected breast within 3 months.I am eligible for a lumpectomy based on my exams and scans.I have decided with my doctor if I will have a lumpectomy or mastectomy.My OncotypeDX DCIS Score report for breast cancer has been uploaded.I have never had invasive breast cancer or DCIS on the same side before.
- Group 1: Arm C (wide local excision)
- Group 2: Arm E (radiation therapy, endocrine therapy)
- Group 3: Arm A (MRI)
- Group 4: Arm B (mastectomy)
- Group 5: Arm D (endocrine therapy)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still openings for individuals to participate in this research?
"As of June 8th 2022, clinicaltrials.gov indicates that this research is not actively recruiting subjects for the trial which commenced on July 1st 2015. There are a total of 4605 other studies seeking enrollees at present, however."
Are there a plethora of Canadian medical centers executing this experiment?
"Phoenixville Hospital in Phoenixville, Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium in Seattle, The Hospital of Central Connecticut in New Britain, and a multitude of other medical facilities across the country are offering this trial."
Share this study with friends
Copy Link
Messenger